JFG
OMGA

Jefferies Financial Group’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Jefferies Financial Group’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,000
Closed -$90.5K – 2077
2023
Q1 		$90.5K Hold
15,000
– – ﹤0.01% 1448
2022
Q4 		$85.7K Buy
+15,000
New +$84.2K ﹤0.01% 1377

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Jefferies Financial Group's OMGA Position: Q2 2023 in Review

Jefferies Financial Group sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2023, closing a stake of 30,824 shares — an estimated $186K sold.

Jefferies Financial Group first reported a position in OMGA in Q4 2022 and held it in 2 quarters. The position peaked at $186K in Q1 2023. 58 funds tracked by Wall St. Rank hold OMGA as of Q2 2023.

  • Jefferies Financial Group reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 30,824 Omega Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $186K.
  • Jefferies Financial Group first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Jefferies Financial Group's Omega Therapeutics, Inc. Common Stock position peaked at $186K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Jefferies Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.